DK138161B - Fremgangsmåde til fremstilling af et stabiliseret farmaceutisk præparat af prostaglandiner af E-rækken. - Google Patents

Fremgangsmåde til fremstilling af et stabiliseret farmaceutisk præparat af prostaglandiner af E-rækken.

Info

Publication number
DK138161B
DK138161B DK167075AA DK167075A DK138161B DK 138161 B DK138161 B DK 138161B DK 167075A A DK167075A A DK 167075AA DK 167075 A DK167075 A DK 167075A DK 138161 B DK138161 B DK 138161B
Authority
DK
Denmark
Prior art keywords
preparation
prostaglandins
series
stabilized pharmaceutical
pharmaceutical preparation
Prior art date
Application number
DK167075AA
Other languages
Danish (da)
English (en)
Other versions
DK167075A (US07166745-20070123-C00016.png
DK138161C (US07166745-20070123-C00016.png
Inventor
Donald Charles Monkhouse
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK167075A publication Critical patent/DK167075A/da
Publication of DK138161B publication Critical patent/DK138161B/da
Application granted granted Critical
Publication of DK138161C publication Critical patent/DK138161C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
DK167075AA 1974-04-19 1975-04-18 Fremgangsmåde til fremstilling af et stabiliseret farmaceutisk præparat af prostaglandiner af E-rækken. DK138161B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (3)

Publication Number Publication Date
DK167075A DK167075A (US07166745-20070123-C00016.png) 1975-10-20
DK138161B true DK138161B (da) 1978-07-24
DK138161C DK138161C (US07166745-20070123-C00016.png) 1979-01-02

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
DK167075AA DK138161B (da) 1974-04-19 1975-04-18 Fremgangsmåde til fremstilling af et stabiliseret farmaceutisk præparat af prostaglandiner af E-rækken.

Country Status (23)

Country Link
US (1) US3927197A (US07166745-20070123-C00016.png)
JP (1) JPS5337408B2 (US07166745-20070123-C00016.png)
AR (1) AR213271A1 (US07166745-20070123-C00016.png)
AT (1) AT348130B (US07166745-20070123-C00016.png)
AU (1) AU470631B2 (US07166745-20070123-C00016.png)
BE (1) BE828065A (US07166745-20070123-C00016.png)
BG (1) BG35326A3 (US07166745-20070123-C00016.png)
CA (1) CA1034044A (US07166745-20070123-C00016.png)
CS (1) CS191244B2 (US07166745-20070123-C00016.png)
DD (1) DD119131A5 (US07166745-20070123-C00016.png)
DE (1) DE2516105C3 (US07166745-20070123-C00016.png)
DK (1) DK138161B (US07166745-20070123-C00016.png)
ES (1) ES436613A1 (US07166745-20070123-C00016.png)
FI (1) FI62220C (US07166745-20070123-C00016.png)
FR (1) FR2267760B1 (US07166745-20070123-C00016.png)
GB (1) GB1474852A (US07166745-20070123-C00016.png)
HU (1) HU175405B (US07166745-20070123-C00016.png)
IE (1) IE40829B1 (US07166745-20070123-C00016.png)
IL (1) IL46994A (US07166745-20070123-C00016.png)
LU (1) LU72320A1 (US07166745-20070123-C00016.png)
NL (1) NL158384B (US07166745-20070123-C00016.png)
PH (1) PH11697A (US07166745-20070123-C00016.png)
SE (1) SE428528B (US07166745-20070123-C00016.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
ES2142409T3 (es) * 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
RU2020130837A (ru) 2018-02-21 2022-03-21 ЭйАй ТЕРАПЬЮТИКС, ИНК. Комбинационная терапия апилимодом и глутаматергическими агентами

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
LU72320A1 (US07166745-20070123-C00016.png) 1976-03-17
PH11697A (en) 1978-05-24
JPS5337408B2 (US07166745-20070123-C00016.png) 1978-10-09
IE40829B1 (en) 1979-08-29
CS191244B2 (en) 1979-06-29
ES436613A1 (es) 1977-04-16
FI751108A (US07166745-20070123-C00016.png) 1975-10-20
SE428528B (sv) 1983-07-11
SE7503723L (sv) 1975-10-20
IL46994A0 (en) 1975-06-25
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15
US3927197A (en) 1975-12-16
AR213271A1 (es) 1979-01-15
DE2516105A1 (de) 1975-10-23
GB1474852A (en) 1977-05-25
BE828065A (fr) 1975-10-17
DK167075A (US07166745-20070123-C00016.png) 1975-10-20
JPS50145515A (US07166745-20070123-C00016.png) 1975-11-21
AU470631B2 (en) 1976-03-25
NL7504274A (nl) 1975-10-21
NL158384B (nl) 1978-11-15
CA1034044A (en) 1978-07-04
DE2516105B2 (de) 1981-01-08
IL46994A (en) 1979-10-31
FR2267760A1 (US07166745-20070123-C00016.png) 1975-11-14
BG35326A3 (en) 1984-03-15
FR2267760B1 (US07166745-20070123-C00016.png) 1978-08-04
IE40829L (en) 1975-10-19
HU175405B (hu) 1980-07-28
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
FI62220B (fi) 1982-08-31
DD119131A5 (US07166745-20070123-C00016.png) 1976-04-12
AU7987775A (en) 1976-03-25
DK138161C (US07166745-20070123-C00016.png) 1979-01-02

Similar Documents

Publication Publication Date Title
DK138655B (da) Fremgangsmåde til fremstilling af N-phosphonomethyl-glycin.
DK135716B (da) Analogifremgangsmåde til fremstilling af methyl-5-propylthio-2-benzimidazolcarbamat.
DK138800B (da) Analogifremgangsmåde til fremstilling af 4-aminoquinazolinderivater.
DK151770C (da) Fremgangsmaade til fremstilling af et pulverformigt vismutholdigt praeparat
NO143477C (no) Fremgangsmaate til fremstilling av et sinkholdig farmasoeytisk preparat.
DK138161B (da) Fremgangsmåde til fremstilling af et stabiliseret farmaceutisk præparat af prostaglandiner af E-rækken.
DK137835B (da) Analogifremgangsmåde til fremstilling af thienothiazinderivater.
DK139846B (da) Analogifremgangsmåde til fremstilling af 3-alkoxypyrazin-2-carboxamider.
DK135796B (da) Fremgangsmåde til fremstilling af alkyl-tert-alkylethere.
DK139580B (da) Analogifremgangsmåde til fremstilling af additionssalte af piperidylindolderivater.
SE7504882L (sv) Forfarande for framstellning av ett nytt farmaceutiskt preparat.
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
DK136529B (da) Analogifremgangsmåde til fremstilling af benzofuranderivater.
NO148373C (no) Fremgangsmaate ved fremstilling av et harpikspeptid.
DK135538B (da) Fremgangsmåde til fremstilling af 17alfa-ethynyl-(5alfa)-2-androsten-17-beta-ol.
SE7508936L (sv) Forfarande for framstellning av en cinnamamid.
DK139140B (da) Fremgangsmåde til fremstilling af dilactonforbindelser.
DK139682B (da) Analogifremgangsmåde til fremstilling af eburnameninderivater.
DK135229B (da) Fremgangsmåde til fremstilling af phosphorpentachlorid.
DK140557B (da) Analogifremgangsmåde til fremstilling af sultiner af 17-hydroxy-3-oxo-17alfa-pregn-4-en-21-sulfinsyrer.
DK137646B (da) Fremgangsmåde til fremstilling af 6-chlor-2-chlormethyl-4-phenylquinazolin-3-oxid.
DK138694B (da) Fremgangsmåde til fremstilling af phenylphosphonothiodichlorid.
DK140670B (da) Analogifremgangsmåde til fremstilling af ergopeptinderivater.
DK137449B (da) Fremgangsmåde til fremstilling af N,N-diallyldichloracetamid.
DK138499B (da) Fremgangsmåde til fremstilling af 11beta-hydroksy-18-alkyløstranforbindelser.

Legal Events

Date Code Title Description
PBP Patent lapsed
B1 Patent granted (law 1993)
PBP Patent lapsed